🔦 #PANCAIDPartnerSpotlight: The University of Cambridge (via @cruk-ci.bsky.social) powers WP2 & WP3, and contributes expertise in circulating tumour DNA (ctDNA) analysis and multi-omic data integration.
#CancerResearch #PancreaticCancer #EarlyDetection
🔦 #PANCAIDPartnerSpotlight: FIBIRYCIS brings expertise in #LiquidBiopsy, cancer genetics & PDAC biomarkers to WP1 – supporting sample & data collection across pancreatic lesions.
Part of the Ramón y Cajal Health Research Institute.
#CancerResearch #PancreaticCancer #EarlyDetection
🔦 This week’s #PANCAIDPartnerSpotlight: KSM Innovation / MACCABI
KSM's strengths are:
📊 Access to 30+yrs of digital health data from 2.7M members
🧬 900K biobank samples
In PANCAID, they contribute to WP1 by providing blood samples
#HealthData #CancerDetection #Biobank
🔦 #PANCAIDPartnerSpotlight: @umeauniversitet.bsky.social 🇸🇪
With unique prediagnostic & diagnostic biobank samples & translational research, Umeå contributes to PANCAID:
📦 WP1: Biomarkers + biobanking
🧭 WP5: Ethical insight from clinical care
@malinasund.bsky.social @danielohlund.bsky.social
🔦 This week in our #PANCAIDPartnerSpotlight:
@medunigraz.at
🔬 Experts in ctDNA & multi-omics
🧪 Driving #LiquidBiopsy innovations
⚡ Active across 4 PANCAID work packages!
Pushing boundaries in early #PancreaticCancer detection.
#Genomics
🔦This week in our #PANCAIDPartnerSpotlight:
@cniostopcancer.bsky.social
🧬GMEG (@nuriamalats.bsky.social) leads AI-driven biomarker discovery
🧪Peinado Lab (@hps2022.bsky.social) pioneers exosome-based diagnostics
Both teams are vital to our mission: a blood test for early #PancreaticCancer detection
